• The company is a leading independent provider of outsourced drug development services to global pharmaceutical and biotech customers


  • DC Advisory was appointed by the company to deliver a competitive financing solution for its strategic growth plans
  • DC Advisory ran a comprehensive financing process, leveraging in-depth industry knowledge and existing deep relationships with US Healthcare / Life Sciences investors
  • The financing process comprised of a number of detailed workstreams, including financial modeling, debt structuring, and negotiating financial documents


  • In May 2024, the company closed on a financing package from a leading global investor in Healthcare / Life Sciences
  • The transaction further demonstrates DC Advisory’s expertise and capabilities advising clients within the Healthcare / Life Sciences capital advisory space